|
This was the year that "genomics" became almost a household word. Thanks to the tremendous publicity generated by publication of the draft
human genome, an event marked by a satellite link-up between US president Bill Clinton and UK prime minister Tony Blair, the public began to
grasp the revolutionary significance of the genetic "Book of Life". It was no coincidence that 2000 was also the year that more money than
ever flowed into biotechnology, the industry at the centre of interpreting genomic data. Biotech shares rose to new heights and companies were
given the financial muscle to pursue cherished projects without relying on handouts from "big pharma", the pharmaceutical giants.
|
